NAV9/19/2017 Chg.-4.6600 Type of yield Investment Focus Investment company
524.3300EUR -0.88% reinvestment Equity Worldwide Bellevue Asset Mgmt. 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2009 - - - - -2.57 6.12 6.42 -1.06 3.16 -11.73 4.92 5.03 -
2010 4.64 4.78 5.80 0.08 -5.05 -3.26 -3.14 0.42 4.28 4.50 1.74 4.27 +19.88%
2011 -5.00 -0.58 -1.77 3.43 3.21 -1.63 -1.22 -13.48 -0.20 1.92 4.02 6.76 -5.94%
2012 12.44 -0.50 3.77 0.96 6.42 1.08 6.96 -0.39 3.53 -9.25 4.57 -1.92 +29.46%
2013 4.41 5.53 9.71 6.48 4.70 -4.20 12.28 -2.09 6.27 -3.63 8.04 -0.23 +56.68%
2014 12.36 4.08 -10.71 -4.63 4.48 8.14 1.15 13.08 3.01 11.02 3.10 2.31 +55.24%
2015 15.70 6.35 4.96 -7.88 12.24 -2.01 2.87 -12.82 -12.03 10.61 7.05 -1.90 +19.90%
2016 -22.80 -5.60 -0.37 3.47 6.31 -9.21 12.44 -2.44 1.99 -11.88 12.34 -3.40 -22.44%
2017 4.88 9.03 -1.17 -0.11 -6.90 5.94 -0.60 3.74 -1.35 - - - -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 19.63% 19.19% 24.08% 29.87% 27.12%
Sharpe ratio 1.00 -0.04 0.32 0.27 0.73
Best month +9.03% +5.94% +12.34% +15.70% +15.70%
Worst month -6.90% -6.90% -11.88% -22.80% -22.80%
Maximum loss -11.01% -11.01% -19.55% -44.38% -44.38%
Outperformance +1.53% - -0.15% -4.30% +26.32%
 
All quotes in EUR

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
BB Adamant Biotech I USD reinvestment 501.2300 +15.60% +18.58%
BB Adamant Biotech I EUR reinvestment 560.4000 +8.14% +28.18%
BB Adamant Biotech I CHF reinvestment 425.3400 +13.31% +21.92%
BB Adamant Biotech I GBP reinvestment 391.7200 - -
BB Adamant Biotech B USD reinvestment 470.7100 +14.76% +15.98%
BB Adamant Biotech B CHF reinvestment 397.3000 +12.48% +19.24%
BB Adamant Biotech B EUR reinvestment 524.3300 +7.35% +25.36%

Performance

YTD  
+13.27%
6 Months
  -0.51%
1 Year  
+7.35%
3 Years  
+25.36%
5 Years  
+142.42%
Since start  
+323.19%
Year
2016
  -22.44%
2015  
+19.90%
2014  
+55.24%
2013  
+56.68%
2012  
+29.46%
2011
  -5.94%
2010  
+19.88%